European Primary Care Cardiovascular Society

Anti-inflammatory agent reduces both first and recurrent events post-MI

3' education - Dec. 19, 2019 - Jean-Claude Tardif, Montreal - AHA 2019, Philadelphia

Educational information

This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.

Faculty

Dr. Jean-Claude Tardif is the Director of the Research Centre at the Montréal Heart Institute and Professor of Medicine at the University of Montréal.

Disclosures

This video was recorded at the congress of the American Heart Association in Philadelphia, on November 16-18, 2019.

Read our summary of the COLCOT data Listen to Aruna Pradhan who interprets the COLCOT data

Share this page with your colleagues and friends: